School of Medicine
Showing 1-50 of 53 Results
-
John Christopher (J.C.) Panagides
Affiliate, Department Funds
Resident in Rad/Interventional RadiologyBioCurrent Integrated Interventional and Diagnostic Radiology (IR/DR) Resident at Stanford Medicine and recent graduate of Harvard Medical School (Class of 2023) with deep interests in emerging applications of interventional and diagnostic radiology, minimally invasive procedures, and biomedical engineering. Extensive experience in biomedical project design and clinical research in predictive analytics, radiology practice management, and population health outcomes.
-
Benjamin Vincent Park
Affiliate, Department Funds
Resident in Rad/Interventional RadiologyCurrent Research and Scholarly InterestsInterventional Oncology, Immunotherapy
-
Shyon Parsa
Affiliate, Department Funds
Resident in MedicineBioShyon earned his B.S. in Biomedical Engineering from the Cockrell School of Engineering at the University of Texas - Austin, graduating with Honors. He completed coursework in Thermodynamics and Transport Phenomena in Living Systems at the Department of Applied Mathematics and Theoretical Physics at Cambridge University under Clare Hall fellow Dr. Kenneth Diller. After graduation, Shyon enrolled in medical school at UT Southwestern, and graduated with an M.D with Distinction in Research and as a member of the Alpha Omega Alpha (AOA) honor society.
He started his internal medicine residency at Stanford University Hospital in 2023. In 2024, he was awarded a Stanford Cardiovascular Institute Seed Grant for his project "An Artificial Intelligence Approach Utilizing Radiomic-Derived Calcium Features on Calcium Scoring CT (CAC-CT) in Cardiovascular Risk Stratification" (Co-PI). In 2025, he was selected for a Young Investigator Award from the National Lipid Association. He is currently leading the NOTIFY-ASCVD trial alongside Co-PIs Fatima Rodriguez and Fahim Abbasi.
His interests include the use of AI in opportunistic coronary artery disease assessment, clinical integration of AI-based diagnostic algorithms through clinical trials, and preventive health advocacy through public policy. He plans to pursue a career in cardiology with a focus on advanced computational imaging techniques, medical device development, and advocacy both in his local communities and abroad. -
Mark E. Pepin, MD, MS, PhD
Affiliate, Department Funds
Fellow in Medicine - Med/Cardiovascular MedicineBioDr. Mark Pepin is a clinical fellow within the Division of Cardiovascular Medicine and Cardiovascular Research Institute at Stanford University Hospital. Born and homeschooled in rural South Carolina, he received a BS in chemical engineering at Clemson University, where he also competed on the NCAA Division 1 Cross Country and Track teams as a distance runner. He completed an MS in biomedical engineering at UC Davis, followed by an MD-PhD at the University of Alabama at Birmingham. Before entering residency training at Brigham and Women’s Hospital, Dr. Pepin was awarded the Humboldt postdoctoral research fellowship to conduct research in Heidelberg, Germany where he studied myocardial epigenetics and metabolism in the context of cardiometabolic heart failure. He has received research funding through the NIH/NHLBI, German Cardiac Society (DGK), and German Center for Cardiovascular Research (DZHK). As a physician-scientist, Dr. Pepin aims to identify and leverage the epigenetic basis of cardiovascular disease to reverse its inherited and acquired forms. In his free time, he enjoys carpentry, running, and exploring the outdoors with his wife and their four children.
-
Sarvesh Periyasamy
Affiliate, Department Funds
Resident in Rad/Interventional RadiologyBioResident in the Integrated Interventional Radiology Residency. I completed my Internship in General Surgery at Stanford Health Care (2024).
I am a former MD-PhD student part of the Medical Scientist Training Program (MSTP) at the University of Wisconsin School of Medicine and Public Health. I earned my PhD in Biomedical Engineering in the Image-Guided Interventions Lab under Dr. Paul Laeseke MD, PhD. My thesis work investigated novel X-ray based image guidance techniques and device development for image-guided interventions.
I am interested in a career where I can integrate advances in physics and engineering research into a translational career as a physician-scientist. My research interests focus on the development and use of advanced imaging techniques to improve diagnosis and intervention of a variety of vascular and oncologic diseases. -
Alexander Darwin Pham
Affiliate, SoM - Admissions
BioDr. Alexander D. Pham specializes in Hematology/Oncology, Hospice and Palliative Care Medicine. He specializes in general medical oncology including breast, genitourinary, and gastrointestinal cancers, as well as all types of benign and malignant hematologic conditions such as chronic leukemias, lymphomas, antiphospholipid syndrome, and coagulation disorders.
Dr. Pham’s early personal experiences with cancer have fueled his desire to develop genuine, intimate relationships with his patients, and to provide compassionate care. He hopes to sustain this commitment to improving quality of care overall, throughout his career. -
Philip A. Pizzo, M.D.
David and Susan Heckerman Professor, Emeritus
BioPhilip Pizzo, MD, is the David and Susan Heckerman Professor Emeritus. Pizzo served as Dean of the Stanford School of Medicine from April 2001 to December 1, 2012. He was Founding Director of the Stanford Distinguished Careers Institute from 2012 - 2022. Pizzo began rabbinical studies at the Academy for Jewish Religion, California in 2022 and studies in Spiritual Care and Counseling at the Jewish Theological Seminary in 2024.
Dr. Pizzo career focused on the diagnosis, management, prevention and treatment of childhood cancers and the infectious complications that occur in children whose immune systems are compromised by cancer and AIDS. He has been a leader in academic medicine and in longevity and the future of higher education.
Pizzo received his MD degree with Honors and Distinction in Research from the University of Rochester in 1970 and completed an internship and residency at the Boston Children’s Hospital. He was a fellow in pediatric oncology at the National Cancer Institute (NCI) and served as head of the NCI’s infectious disease section, chief of pediatric oncology, and scientific director for the Division of Clinical Sciences between. Before joining Stanford in 2001, he was the physician-in-chief of Boston Children’s Hospital and Chair of the Department of Pediatrics at Harvard Medical School, where he was also the Thomas Morgan Rotch Professor of Pediatrics.
Dr. Pizzo is the author of more than 650 scientific articles and 16 books and monographs. He also served as Editor-in-Chief of Current Opinion in Pediatrics from 2012 - 2019. He co-led the National Academy of Medicine 2011 report Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research; and “Dying in America: Improving Quality and Honoring Individual Preferences at the End of Life” that was published in 2015.
Pizzo has received numerous awards and honors, including the Public Health Service Outstanding Service Medal in 1995, the Barbara Bohen Pfiefer Award for Scientific Excellence in 1991, the Elizabeth Kubler-Ross Award in 2008, the Ronald McDonald Charities “Award of Excellence” in 2009, and the John and Emma Bonica Public Service Award in 2013. He is the 2012 recipient of the John Howland Award, the highest honor for lifetime achievement bestowed by the American Pediatric Society. In 2019 he received the John Stearns Medal from the New York Academy of Medicine. Pizzo received the 2021 International Immunocompromised Host Society’s Lifetime Distinguished Career Award. He received the Dean’s Medal from the University of Rochester in 2023.
Pizzo has been elected to the Association of American Physicians, the American Society of Clinical Investigation, the American Pediatric Society, the National Academy of Medicine. He has served as Chair of the Association of Academic Health Centers and Chair of the Council of Deans of the Association of American Medical Colleges. He was elected to the Board of Directors of the American Society for Clinical Oncology and the Infectious Diseases Society of America. He was President of the International Immunocompromised Host Society between1998 – 2011, and he served on the Governing Board for the California Institute of Regenerative Medicine from 2004 - 2012. Pizzo was elected to the Board of Trustees of the University of Rochester from 2009 - 2022 and the Board of Overseers of Koc University in Istanbul, Turkey from 2010 - 2022. He served Academic Advisory Council for Merritt Hawkins between 2015 - 2022., and the Advisory Board to the Milken Institute Center on Aging from 2015 - 2022. He was elected to the Board of Directors of the Ludwig Institute for Cancer Research from 2012- 2022. In 2015 Pizzo was elected to the Board of Directors of Global Blood Therapeutics through 2023, and in 2019 he was elected to the Board of Directors of Hillel at Stanford through 2023.
